Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
Circulating IGF-1 levels and 27 digestive diseases: 461,401 UK biobank prospective analysis
Growth Hormone and IGF Research
June 2026
Yang W.
Somatostatin Effect on Growth Factors in Hepatocellular Carcinoma
Current Issues in Molecular Biology
February 2026
Tsakou A.
Open Access
Serum Insulin-Like Growth Factor 1 and the Prognosis of Patients With Advanced Liver Diseases: A Meta-Analysis
Clinical and Translational Gastroenterology
1 July 2025
Liu Y.
Open Access
Insulin-like Growth Factor-1 Levels Reflect Muscle and Bone Health and Determine Complications and Mortality in Decompensated Cirrhosis
Journal of Clinical and Experimental Hepatology
1 January 2025
Kaur P.
All Open Access, Green
Sarcopenia in liver cirrhosis: Prevalence, pathophysiology and therapeutic strategies
Analytical Biochemistry
15 June 2022
Fox R.
All Open Access, Green
Value of IGF-1, RBP, and CHE in the diagnosis of liver cirrhosis
Chinese Journal of Clinical Research
November 2021
Duan X.X.
Low Growth Hormone Levels Predict Poor Outcome of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure
Frontiers in Medicine
6 July 2021
Wu D.
Open Access
Nutraceuticals for the treatment of sarcopenia in chronic liver disease
Clinical Nutrition Espen
February 2021
Hey P.
Nutrition in Chronic Liver Disease: Consensus Statement of the Indian National Association for Study of the Liver
Journal of Clinical and Experimental Hepatology
1 January 2021
Puri P.
All Open Access, Green
Value of the controlling nutritional status score and psoas muscle thickness per height in predicting prognosis in liver transplantation
World Journal of Clinical Cases
2021
Dai X.
Open Access
Research advances in hepatocellular carcinoma-related sarcopenia
Journal of Clinical Hepatology
July 2020
Shen S.
Pathogenesis of sarcopenia in liver cirrhosis and current status of its diagnosis and treatment
Journal of Clinical Hepatology
April 2020
Liu J.
Molecular prognosis in liver cirrhosis
Genomic and Precision Medicine Infectious and Inflammatory Disease
1 January 2019
Athuluri-Divakar S.K.
Upcoming pharmacological and interventional therapies for the treatment of physical frailty and sarcopenia
Frailty and Sarcopenia in Cirrhosis the Basics the Challenges and the Future
1 January 2019
Hey P.
Factors correlated with serum insulin-like growth factor-I levels in health check-up subjects
Growth Hormone and IGF Research
June 2018
Matsumoto R.
Insulin-like growth factor (IGF) system in liver diseases
International Journal of Molecular Sciences
May 2018
Adamek A.
Open Access
Sarcopenia in patients with advanced liver disease
Current Protein and Peptide Science
2018
Ponziani F.R.
Molecular prognostic prediction in liver cirrhosis
World Journal of Gastroenterology
28 September 2015
Goossens N.
Open Access
IGF-1 decreases portal vein endotoxin via regulating intestinal tight junctions and plays a role in attenuating portal hypertension of cirrhotic rats
BMC Gastroenterology
July 08, 2015
Zhao T.Y.
Open Access
Lower levels of insulin-like growth factor-1 standard deviation score are associated with histological severity of non-alcoholic fatty liver disease
Hepatology Research
1 July 2015
Sumida Y.
Growth hormone/insulin-like growth factor 1 dynamics in adult living donor liver transplantation
Liver Transplantation
September 2014
Jara M.
Open Access